Endpoint Validation Study (0524A-015)
Clinical trial NCT00533676 · COMPLETED
Trial details
- NCT number
- NCT00533676
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2006-12-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.